Latest / Cell & Gene: The Podcast

Defining Product Roles and Navigating FDA Approval with Monika Swietlicka
We love to hear from our listeners. Send us a message.
Episode 2 of FDA Fridays, the special series from Cell & Gene: The Podcast, features Host Erin Harris' discussion with regulatory expert Monika Swietlicka, Principal, Regulatory Strategy, Halloran Consulting Group about the key strategies and challenges in navigating FDA regulation for cell and gene therapies. Their conversation covers the importance of defining a therapy’s intended role (curative, chronic, or adjunctive) early in development, the different regulatory expectations based on disease context and patient population, and the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.